RTI Surgical, a CDMO in regenerative medicine, has completed its $15 million Class III medical device facility in Alachua, Florida.   The new 5,000 sqft clean room significantly expands RTI’s proprietary Tutoplast Tissue Sterilization Process facility, supporting increased customer demand for Tutoplast processed implants and RTI’s upcoming clinical study of the safety and effectiveness of Cortiva Allograft Dermis (ADM) in implant-based breast reconstruction.   The Tutoplast Tissue Sterilizat...